Share & Key figures
Marinomed Biotech AG has been listed on the Vienna Stock Exchange since 1 February 2019. The shares are listed in the Prime Market segment and included in the ATX Prime Index.
| Share data | |
| ISIN | ATMARINOMED6 |
| Share class | No-par bearer shares |
| Nominal capital | EUR 1,496,287 (1,496,287 no-par value shares) |
| Ticker symbol | MARI |
| Issue price (IPO) on 1.2.2019 | EUR 75.00 |
| Market capitalization (at issue price) | EUR 97.4 Mio. |
For current price information please follow the link to the website of the Vienna Stock Exchange.
Coverage
Erste Bank Group AG (Vladimira Urbankova)
Intron Health (Naresh Chouhan)
FMR/Oddo Seydler (Mohamad Vaseghi)
Stifel Europe Bank AG (Dr. Daniel Grigat)
| Selected key financial figures | |||
| in EUR Mio. | 2021 | 2020 | 2019 |
| Revenues | 11.63 | 8.12 | 6.14 |
| Operating result (EBIT) | -4.14 | -5.82 | -6.21 |
| Loss for the year | -5.89 | -6.01 | -7.22 |
| Cash and cash equivalents per 31.12. | 5.80 | 9.21 | 12.02 |
| Balance sheet total per 31.12. | 21.34 | 23.50 | 19.50 |
| Net cash flow | -3.40 | -2.81 | 10.30 |